Literature DB >> 17628763

[Kidney insufficiency and cardiovascular disease].

B Weidtmann1, H Schunkert.   

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in patients with chronic renal disease. Severe cardiac and arterial disorders such as left ventricular hypertrophy, coronary artery disease, and arteriosclerosis of the large vessels are already evident in early renal disease, even in young patients. Despite major advances in dialysis therapy and treatment options for acute coronary syndromes, mortality remains high--up to 10-30 times higher than in the general population. The increased risk for cardiovascular disorders results from the additive effect of traditional risk factors, volume overload, and endocrine and metabolic abnormalities in uremia. During the course of the renal disease, the progression of CVD disease manifestations significantly influences outcome. Thus, preventive measures and optimal treatment are mandatory and should be among the main targets of early management of patients with chronic renal disease.

Entities:  

Mesh:

Year:  2007        PMID: 17628763     DOI: 10.1007/s00108-007-1901-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

1.  Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis.

Authors:  Carmine Zoccali; Francesco Antonio Benedetto; Francesca Mallamaci; Giovanni Tripepi; Giuseppe Giacone; Alessandro Cataliotti; Giuseppe Seminara; Benedetta Stancanelli; Lorenzo Salvatore Malatino
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

Review 2.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

3.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

Authors: 
Journal:  Am J Kidney Dis       Date:  2005-04       Impact factor: 8.860

Review 4.  Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge.

Authors:  Adeera Levin
Journal:  Kidney Int Suppl       Date:  2002-05       Impact factor: 10.545

5.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis.

Authors:  C A Herzog; J Z Ma; A J Collins
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

6.  Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?

Authors:  M H Rubenstein; L C Harrell; B V Sheynberg; H Schunkert; H Bazari; I F Palacios
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

7.  Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH.

Authors:  K Amann; J Törnig; C Flechtenmacher; A Nabokov; G Mall; E Ritz
Journal:  Nephrol Dial Transplant       Date:  1995-11       Impact factor: 5.992

8.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Authors:  Hallvard Holdaas; Bengt Fellström; Alan G Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Edward Cole; Bart Maes; Patrice Ambühl; Anders G Olsson; Anders Hartmann; Dag O Solbu; Terje R Pedersen
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  Outcome and risk factors of ischemic heart disease in chronic uremia.

Authors:  P S Parfrey; R N Foley; J D Harnett; G M Kent; D Murray; P E Barre
Journal:  Kidney Int       Date:  1996-05       Impact factor: 10.612

10.  Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study.

Authors:  J Hüting; W Kramer; G Schütterle; V Wizemann
Journal:  Nephron       Date:  1988       Impact factor: 2.847

View more
  2 in total

Review 1.  [The role of platelets in atherosclerosis, diabetes mellitus, and chronic kidney disease. An attempt at explaining the TREAT study results].

Authors:  Norbert Maurin
Journal:  Med Klin (Munich)       Date:  2010-05-26

2.  Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy.

Authors:  Ke Yang; Cheng Wang; Ling Nie; Xiaohui Zhao; Jun Gu; Xu Guan; Song Wang; Tangli Xiao; Xinli Xu; Ting He; Xuefeng Xia; Junping Wang; Jinghong Zhao
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.